Journal
AAPS JOURNAL
Volume 16, Issue 3, Pages 504-515Publisher
SPRINGER
DOI: 10.1208/s12248-014-9583-x
Keywords
critical reagents; ligand binding assays; lot changes; recommendations; stability
Categories
Ask authors/readers for more resources
The L4 Global Harmonization Team on reagents and their stability focused on the management of critical reagents for pharmacokinetic, immunogenicity, and biomarker ligand binding assays. Regulatory guidance recognizes that reagents are important for ligand binding assays but do not address numerous aspects of critical reagent life cycle management. Reagents can be obtained from external vendors or developed internally, but regardless of their source, there are numerous considerations for their reliable long-term use. The authors have identified current best practices and provided recommendations for critical reagent lot changes, stability management, and documentation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available